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ABSTRACT
Incorporating Disease-Oriented Smoking Cessation Education into the Care of Smokers
with Peripheral Arterial Disease
Donte Newsom
Background and Significance
Smoking is a major health issue in the United States, with nearly 18% of the population
being reported as active smokers. Smoking is a contributing factor to many chronic diseases,
such as peripheral arterial disease, and is a public health concern significant to nursing practice.
Problem Statement
Despite evidence of the detriments of smoking, many patients with peripheral arterial
disease receive minimal smoking cessation education, and cessation aides are rarely utilized.
Project Design
A disease-oriented smoking cessation education intervention was developed modeling the
5 A’s of smoking cessation and utilized for active smokers with peripheral arterial disease. This
pilot study evaluated the feasibility of implementing the practice change in a specialty practice.
Evaluation Plan
Patients’ number of cigarettes smoked daily, readiness to change, and attitudes towards
the intervention were evaluated. Percent of eligible people who obtained the intervention were
tracked to evaluate process. The cost-effectiveness of the intervention was a major consideration.
Results
The intervention reached 69% of those who met inclusion criteria. Most participants
found the intervention helpful. Participants reduced smoking by 60.8% and moved forward
toward smoking cessation by 1.0 stage of change. A cost/benefit analysis revealed the
intervention was cost-effective.
Recommendations
This cost-effective practice change should be implemented across a variety of practice
settings as part of comprehensive healthcare approach to smoking cessation.
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Incorporating Disease-Oriented Smoking Cessation Education into the Care of Smokers with
Peripheral Arterial Disease
Smoking is a major public health hazard that is of concern to all levels of nursing
practice. Prevention is a key role of the advanced practice nurse, and smoking is a preventable
risk factor for many diseases. One of the many diseases that is attributable to smoking is
peripheral arterial disease (Hennrikus et al., 2010). Despite evidence of the detriments of
smoking, many patients receive minimal education related to smoking cessation, and cessation
aides are rarely utilized (Aiman et al., 2014; Mannava & Money, 2007; Verma et al., 2011). This
project evaluated the feasibility of implementing an intervention that identified current smokers
with peripheral arterial disease in a small specialty practice and provided them with diseaseoriented smoking cessation education to help prevent disease recurrence or worsening.
Background
Working as a nurse practitioner at a small vascular surgery practice in North Central West
Virginia offers many challenges, but also many opportunities. The patient population is rural,
97% white, and the majority are from a lower socioeconomic background. Almost 24% of
patients are current smokers, with an additional 38% being former smokers. Only 37% of
patients have never smoked. Despite its challenges, being able to work and help patients from
one’s own community is often rewarding. The providers and staff are committed to providing
excellent patient care to patients diagnosed with a variety of vascular diseases, such as
abdominal aortic aneurysms, carotid artery disease, peripheral arterial disease, venous
insufficiency, and wounds. Among these, peripheral arterial disease is the most prevalent and
lifestyle impacting disease and was the focus for the purposes of this project.
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Problem Statements
Smoking is a major health issue in the United States, with nearly 18% of the United
States population being reported as active smokers (CDC, 2015). Smoking is a leading
contributor to death and disease. More than 16 million people in the U.S. have diseases caused
by smoking, and one in five deaths in the U.S. are caused by smoking, totaling nearly 480,000
each year. Subsequently, smoking is a major economic burden, costing the medical system $193
billion a year (HealthyPeople.gov).
Peripheral arterial disease (PAD) is a vascular disorder involving the narrowing of the
arterial blood vessels distal to the aortic arch (Sontheimer, 2006). The reported prevalence of
PAD varies widely between studies and is affected by age and other risk factors; it affects 3-10%
of the general population, and 15-20% of adults over 70 years of age (Hennion & Siano, 2013).
In one study, when evaluating smoking in the sub-population of people with peripheral arterial
disease, it was found that approximately 26% smoke, and as many as 79% have a smoking
history, either current or former (Dunkley, et al., 2007). Smoking is a top modifiable risk factor
contributing to PAD, second only to diabetes (Alexopoulos, Vlachopoulos, & Stefanadis, 2010;
Conen et al., 2011; Hennrikus et al., 2010; Federman and Kravetz, 2007; Katsiki, Papadopoulou,
Fachantidou, & Mikhailidis, 2013; Lu, Mackay, & Pell, 2014; Moyer, 2013; Muir, 2009;
Paraskevas, Papas, Pavlidis, Bessias, & Andrikopoulos, 2008; Simmons, Steffen, & Sanders,
2012; Sontheimer, 2006; Steffen, Duprez, Boucher, Ershow, & Hirch, 2008; Verma, Prasad,
Elkadi, & Chi, 2011;Watson, Watson, & Pater, 2006; Wiley, Kumar, & Vacek, 2012). Increased
pack years of smoking increases the risks of developing PAD, and increases the morbidity and
mortality of the diagnosis, demonstrating a dose-dependent relationship between the two (Au,
Golledge, Walker, Haigh, & Nelson, 2013; Hankey, Norman, & Eikelboom, 2006; Katsiki et al.,
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2013; Lee et al., 2011; Paraskevas et al., 2008; Watson, Watson, & Pater, 2006). Additionally,
former smokers, or individuals who quit smoking more than 10 years ago, may still have
increased risk of developing PAD and suffering increased morbidity and mortality (Aboyans et
al., 2011; Conen et al., 2011; Lu, Mackay, & Pell, 2014; Verma et al., 2011). Finally, smoking
increases the inherent risks of PAD, including leg amputation, coronary artery disease, stroke,
and mortality (Madia, 2012; Steffen et al., 2008; Verma et al., 2011).
There have been few randomized controlled trials (RCTs) of methods of smoking
cessation specifically for patients with peripheral arterial disease (Hankey et al., 2006; Hennion
& Siano, 2013; Hennrikus et al., 2010). However, smoking cessation improves the morbidity
and slows disease progression by increasing walking distance, doubling five-year survival rates,
and reducing the incidence of post-operative complications (Au et al., 2013; Hennrikus et al.,
2010; Katsiki et al., 2013). Clinical practice guidelines offer strong evidence-based
recommendations supporting smoking cessation interventions for patients with PAD. There is
also consensus evidence in favor of screening patients 50 years and older who have a history of
smoking for PAD (Hennion & Siano, 2013; Layden, et al, 2012; Moyer, 2013). Unfortunately,
there is still a large percentage of patients with PAD that are not treated adequately with riskfactor reduction such as smoking cessation (Aiman et al., 2014; Federman and Kravetz, 2007;
Lumsden and Rice, 2006).
Purpose
The purpose of this project was to evaluate the feasibility of implementing an
intervention that identifies current smokers with peripheral arterial disease (PAD) in a small
specialty practice and providing them with disease-oriented smoking cessation education to help
prevent disease recurrence or worsening.
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Significance of the Project
Smoking is a key modifiable risk factor linked to the development of peripheral arterial
disease, yet a large percentage of patients who are identified as current smokers do not receive
smoking cessation education and are under diagnosed and undertreated (Mannava & Money,
2007; Aiman, et al., 2014). The goal of this project was to identify current smokers with
peripheral arterial disease and provide them with disease-oriented smoking cessation education
to help prevent disease recurrence or worsening. Providing disease-oriented smoking cessation
education meant that patients received smoking cessation education that focused on how
smoking impacts their disease process, and how quitting could improve their symptoms and
health outcomes. It was proposed that creating an informational link through disease-oriented
smoking cessation education may help patients reduce or eliminate their smoking. For example,
it is known that smoking cessation improves symptoms of PAD such as walking distance and
claudication and reduces disease recurrence and overall disease morbidity and mortality (Au et
al., 2013; Katsiki et al., 2013). Educating patients on the benefits of smoking cessation to
improve their current symptoms and health likely increased their likelihood of quitting.
Literature Review and Synthesis
A systematic review of the literature of the relationship between smoking cessation
interventions and peripheral artery diseases was conducted in July of 2016 utilizing EBSCOHost
with CINHAL, HealthSource: Nursing/Academic Edition, Academic Search Complete,
MEDLINE, PsychINFO and PsychArticles as the selected databases. “Smoking cessation” and
“vascular surgery”, “smoking cessation” and “interventions”, “smoking cessation interventions”
and “peripheral arterial disease”, and “smoking cessation” and “peripheral arterial disease” were
the mesh terms used for the search. Peer reviewed, English language articles about smoking and

INCORPORATING SMOKING CESSATION EDUCATION

5

smoking cessation as it related to peripheral arterial disease compromised the inclusion criteria.
Exclusion criteria included studies that did not relate to smoking or smoking cessation and PAD,
non-English articles, and non-peer-reviewed articles. A total of 34 articles were included in this
brief review of the literature.
Peripheral Arterial Disease, Smoking, and Smoking Cessation
Numerous articles related to smoking and peripheral arterial disease were reviewed to
gain a broad understanding of the literature related to smoking and smoking cessation’s impact
on peripheral arterial disease. Peripheral arterial disease is the presence of systemic
atherosclerosis in arteries distal to the aortic arch (Sontheimer, 2006). It most often affects the
arteries that supply the legs, but also can occur in the arms, brain, stomach, kidney, or other vital
organs (Steffen et al., 2008). Peripheral arterial disease of the extremities is diagnosed clinically
by the ankle brachial index (ABI), a diagnostic tool which is assessed with standard protocols
and calculates the index using a ratio of the highest systolic blood pressure in the arm compared
with the highest systolic pressure in the legs. Peripheral arterial disease is defined by an ABI of
0.90 or less, and the ABI is associated with high sensitivity and specificity (Aboyans et al., 2011;
Aiman et al., 2014; Aronow, 2007a; Aronow, 2007b; Aronow, 2010; Federman and Kravetz,
2007; Hankey et al., 2006; Hennion & Siano, 2013; Hennrikus et al., 2010; Hiatt & Krantz,
2006; Kroger et al., 2009; Lee et al., 2011; Madia, 2012; Moyer, 2013; Simmons, Steffen, &
Sanders, 2012; Sontheimer, 2006; Steffen et al., 2008; Verma et al., 2011; Watson, Watson, &
Pater, 2006; Wiley, Kumar, & Vacek, 2012). Low ABIs have been proven to be an independent
risk factor of cardiovascular risk and as a predictor for future cardiac events such as coronary
artery disease, stroke, and death (Aronow, 2007; Hankey et al., 2006; Steffen et al., 2008).
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Pathophysiology. Major pathophysiological factors involved in the peripheral arterial
disease (PAD) include platelet activation and thrombosis, along with arterial stiffness. As lesions
develop and increase in complexity, additional factors such as ulceration, rupture, or erosion also
occur (Alexopoulos, Vlachopoulos, & Stefanadis, 2010; Watson, Watson, & Pater, 2006). Risk
factors such as cigarette smoking contribute further to the process due to constriction and
damage of arteries which potentiates endothelial dysfunction and alters lipoprotein metabolism,
coagulation, and platelet function (Lee et al., 2011). Other studies discuss the response to injury
model of atherosclerosis, which links smoking to endothelial dysfunction, leading to an
inflammatory host response that leads to vascular remodeling, followed by plaque formation, and
eventually a complicated atherosclerotic lesion (Haugen, Casserly, Regensteiner, & Hiatt, 2007).
Passive smoking has also been associated with increased arterial stiffness (Katsiki et al., 2013).
Current smoking, diabetes, BMI, blood pressure, and cholesterol are the most relevant mediators
of PAD (Aboyans et al., 2011; Aronow, 2007a; Aronow, 2007b; Aronow, 2010; Federman and
Kravetz, 2007; Hankey et al., 2006; Hennion & Siano, 2013; Hiatt & Krantz, 2006; Kroger et al.,
2009; Lovell, Myers, Forbes, Dresser, & Weiss, 2011; Lumsden and Rice, 2006; Madia, 2012;
Mannava & Money, 2007; Moyer, 2013; Muir, 2009; Simmons, Steffen, & Sanders, 2012;
Steffen et al., 2008; Verma et al., 2011; Watson, Watson, & Pater, 2006; Wiley, Kumar, & Vacek,
2012).
Significance. Peripheral arterial disease (PAD) is associated with a number of
detrimental health effects such as amputation, heart attack, stroke, and death (Aiman et al., 2014;
Alexopoulos, Vlachopoulos, & Stefanadis, 2010; Aronow, 2007a; Aronow, 2007b; Aronow,
2010; Haugen et al., 2007; Hennion & Siano, 2013; Hiatt & Krantz, 2006; Lee et al., 2011;
Lovell et al., 2011; Moyer, 2013; Muir, 2009; Simmons, Steffen, & Sanders, 2012; Steffen et al.,
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2008; Verma et al., 2011; Watson, Watson, & Pater, 2006; Wiley, Kumar, & Vacek, 2012).
Notably, people with PAD had a 30% increase in risk of death within five years, and 50% within
ten years, mostly secondary to myocardial infarction (Dunkley, Stone, Sayers, Farooqi, &
Khunti, 2007; Hankey et al., 2006). Additionally, peripheral arterial disease is associated with a
decreased quality of life (Watson, Watson, & Pater, 2006; Wiggers et al., 2006). Factors such a
low socioeconomic status have been associated with higher cardiovascular morbidity and
mortality when compared to the population and several articles recommend prevention programs
that specifically target individuals of lower income and education (Aiman et al., 2014; Kroger et
al., 2009).
Despite the evidence, many patients with PAD remain untreated (Aiman et al., 2014;
Mannava & Money, 2007; Verma et al., 2011). Furthermore, less than one in four Americans
under 50 were aware of the existence of PAD, and 50% of people did not know that risk factors
such as diabetes and smoking increased the risks (Steffen et al., 2008).
Smoking and peripheral arterial disease. Peripheral arterial disease (PAD) has many
risk factors that contribute to the development and progression of the disease. Among them,
smoking has been identified as the single most important modifiable risk factor, known to
accelerate the development and progression of the disease and symptoms of the disease such as
claudication, which is pain associated with walking that relieves with rest (Hennrikus et al.,
2010). As many as 90% of people with PAD have at least one of the risk factors, either smoking
or diabetes (Federman and Kravetz, 2007). Diagnosis of PAD in patients who smoke is made up
to a decade sooner than non-smokers and is associated with earlier onset of symptoms (Muir,
2009; Verma et al., 2011). Smoking increased the risk of negative surgical intervention outcomes
such as graft failure and restenosis by more than double (Aronow, 2007; Federman and Kravetz,
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2007; Verma et al., 2011; Watson, Watson, & Pater, 2006). There is a definitive dose-dependent
relationship with smoking, meaning that patients with greater pack-years of smoking tend to
have increased morbidity and mortality (Au et al., 2013; Hankey et al., 2006; Katsiki et al., 2013;
Lee et al., 2011; Paraskevas et al., 2008; Watson, Watson, & Pater, 2006). Smokers are two to
four times more likely to develop PAD and more frequently develop advanced disease
complications such as critical limb ischemia and amputation. Past smoking, too, had borderline
association with low ABIs (Aboyans et al., 2011; Conen et al., 2011; Lu, Mackay, & Pell, 2014;
Verma et al., 2011). There is evidence that there may be a greater association of smoking to PAD
than that of coronary artery disease (Katsiki et al., 2013; Lu, Mackay, & Pell, 2014; Madia, 2012;
Muir, 2009; Steffen et al., 2008; Verma et al., 2011; Watson, Watson, & Pater, 2006).
Additionally, patients with PAD are less likely to receive appropriate treatment of risk factors
than those being treated for coronary artery disease (Lumsden and Rice, 2006).
Smoking cessation. Smoking cessation is the most cost-effective treatment available for
the treatment of PAD and is widely accepted as one of the main treatment goals for people with
PAD who smoke (Katsiki et al., 2013; Wiley, Kumar, & Vacek, 2012). Smoking cessation
improves walking distance, doubles five-year survival rates, and reduces the incidence of postoperative complications (Au et al., 2013; Hennrikus et al., 2010; Katsiki et al., 2013). Continued
smoking was found to increase the risk of amputation in patients with PAD, specifically those
with intermittent claudication (Aronow, 2007). Poor utilization of smoking cessation
interventions by the medical community has been identified in the literature, with
recommendations to initiate education on the importance of smoking cessation education earlier,
such as in undergraduate programs, and integrate it into the curriculum of medical schools
(Aiman et al., 2014). Importantly, while the target is to quit smoking, it has been found that
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cutting down smoking may have beneficial effects (Alexopoulos, Vlachopoulos, & Stefanadis,
2010). Also, patients who attempt smoking cessation by switching to chewing tobacco were
found to have higher rates of mortality than those who chose abstinence (Katsiki et al., 2013).
Smoking cessation interventions. Smoking cessation is an effective but underutilized
treatment for peripheral arterial disease. Though there have been few randomized controlled
trials (RCTs) of methods of smoking cessation specifically for patients with peripheral arterial
disease (Hankey et al., 2006; Hennion & Siano, 2013; Hennrikus et al., 2010); there are
observational data from studies that indicate that smoking cessation is associated with decreased
morbidity and reduced disease progression (Hennion & Siano, 2013). Additionally, clinical
practice guidelines offer strong recommendations and have strong evidence in favor of smoking
cessation for patients with PAD (Layden, Michaels, Bermingham, Higgins, & Guideline
Development Group, 2012; Simmons, Steffen, & Sanders, 2012). In their study of patients with
PAD, Hennrikus, et al. found that many people who are current smokers are interested in and
receptive to formal smoking cessation education programs, and many can successfully quit when
provided with the appropriate resources (2010). Their intensive intervention helped 21% of
study participants randomized to the intensive group to quit by utilizing physician advice to quit,
counseling related to smoking and the link to PAD, motivational interviewing to increase
motivation to quit, cognitive behavioral therapy counseling to develop a quit plan, and
information about pharmacological aides for smoking cessation (Hennrikus et al., 2010). In their
study of the application of the Chronic Care Model on PAD, a nurse-led team of researchers
concluded that nursing involvement in empowering people to make life-changing differences
decreased vascular risk factors and improved outcomes for high-risk population as evidenced by
significant decreases in the sample’s blood pressure and cholesterol, and 16% of people who
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smoked at baseline successfully quit with the utilization of smoking cessation counseling at
every visit and telephone follow-up (Lovell et al., 2011).
Additional literature on brief interventions. Brief interventions refer to practices
which identify and address potential problems during short interactions and motivate individuals
to change (MDQuit, 2012a). The National Institute for Health and Care Excellence (NICE)
guidance offers recommendations related to smoking and brief interventions. The guidance is
for practitioners to ask people who smoke how interested they are in quitting, referring those
who want to quit to support services, offer smoking cessation aides to those unwilling or unable
to accept a referral, be aware of agencies that offer advice and support on how to stop smoking,
and have a system in place to know whether patients smoke (NICE, 2006). For smoking
cessation, the goal of a brief intervention is to enhance tobacco users’ motivation to change and
then connect them with evidence-based resources to make their change attempt successful
(MDQuit, 2012a). Brief interventions are one step of the well-known public health approach
SBIRT, which stands for screening, brief intervention, and referral to treatment (MDQuit,
2012b).
A widely known brief intervention is the “5 A’s” approach to smoking cessation. The “5
A’s” is a brief, goal-directed method to address tobacco use with patients with the goal of
meeting the user’s needs in terms of readiness to quit (MDQuit, 2012a). The 5 A’s include Ask,
Advise, Assess, Assist, and Arrange. The 5 A’s can be tailored to the setting and can involve an
entire clinic’s staff to accomplish the goal of supporting tobacco users. When applying the 5
A’s, clinicians (1) ask about tobacco use at each encounter to identify the patient’s current use
and past smoking patterns; (2) advise patients who are active tobacco users to quit in a clear,
strong, personalized manner; (3) assess a patient’s willingness to quit using a standardized scale,
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or utilize the stages of change from the Transtheoretical Model of Behavior Change to determine
the patient’s readiness to change; (4) assist the patient in moving toward a successful quit
attempt through a chosen intervention; and (5) arrange follow up contact with the patient, either
in person or via telephone to continue support in the quit attempt (MDQuit, 2012a).
Evidence-based practice. Guidelines are collections of evidenced-based
recommendations related to specific topics that are published periodically to help guide
management of different diseases in the population. Several guidelines are available to help
guide the management of peripheral arterial disease (PAD). The National Institute for Health
and Care Excellence (NICE), a United Kingdom based organization recommends that all people
with peripheral arterial disease receive information, advice, support, and treatment for smoking
cessation. For screening, they recommend a thorough vascular history and physical and an
Ankle-Brachial Index (ABI) study to assess people who display potential symptoms related to
PAD, with no mention of age or risk factors (Layden et al., 2012). The American College of
Cardiology and American Heart Association recommend risk factor modification, including
smoking cessation, as a major treatment focus. For screening, they recommend the anklebrachial index study for patients with symptoms related to PAD or age 65 and older to be
screened, along with people 50 years and older who have a history of smoking or diabetes
(Simmons, Steffen, & Sanders, 2012). Alternatively, the U.S. Preventative Services Task Force
does not offer recommendation for screening of asymptomatic adults without a known history of
peripheral arterial disease, coronary artery disease, chronic kidney disease, or diabetes. They do,
however, note that important risk factors to consider include age, diabetes, smoking,
hypertension, high cholesterol, obesity, and physical inactivity (Moyer, 2013).
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Synthesis
Peripheral arterial disease (PAD), an atherosclerotic disease which affects arterial vessels
distal to the aortic arch impacted by atherosclerotic processes which promote platelet activation
and thrombosis along with arterial stiffness is defined by an ankle brachial index test less than
0.90. Peripheral arterial disease is present in 3-10% of the population and is largely impacted by
both non-modifiable risk factors such as age and family history, and by modifiable risk factors
such as smoking. It is associated with a variety of health problems such as amputations, heart
attacks, strokes, death, and a decreased quality of life. Despite its prevalence and ill effects, it is
widely under diagnosed and undertreated. Smoking is the top modifiable risk factor for PAD and
its presence is shown to make a person two to four times more likely to develop the disease. In
addition to increasing prevalence, smoking is known to increase the morbidity and mortality
associated with smoking. Alternatively, smoking cessation is the most cost-effective treatment
available for the treatment of PAD and is the main treatment goal for patients with PAD who
smoke. Smoking cessation interventions should be a standard of care for healthcare
organizations which treat patients with PAD.
Theoretical Framework
The Transtheoretical Model of Health Behavior Change supported the implementation of
this system change. The model theorizes that health behavior change involves navigation
through six stages of change to integrate processes and principles of change from different
theories of intervention. The model’s foundations are in multiple leading theories of
psychotherapy and behavior change.
There are seven assumptions that lay the foundation for the theory (Prochaska & Velicer,
1997). The assumptions are as follows: 1) Behavior change is complex and cannot be explained
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fully by any single theory; 2) behavior change develops over time via a sequence of stages; 3)
stages of change are stable, yet pliable and open to change; 4) populations cannot move from the
early stages of change without planned interventions; 5) traditional action-oriented prevention
programs are best suited for population who are prepared for action and therefore do not meet the
needs of most at-risk populations; 6) to achieve progress through the stages of change, specific
processes and principles of change need to be applied at specific stages; 7) biological, social,
and self-control are all elements which affect chronic behavior patterns (Prochaska & Velicer,
1997, p. 41).
The model is defined by several core constructs, including the stages of change, the
processes of change, and the concepts of decisional balance, self-efficacy, and temptations
(Prochaska & Velicer, 1997, 39-40). The six stages of change in the model are precontemplation,
contemplation, preparation, action, maintenance, and termination. In the precontemplation stage,
a person does not intend to make a change in the foreseeable future, either from ignorance or
discouragement from previous failures. In the contemplation stage, a person intends to change in
the near future but is ambivalent towards change because of his or her acute awareness of both
the pros and cons of change. The balance between the pros and cons can lead people to remain
in this stage for long periods of time, and often makes them poor candidates for action-oriented
programs. In the preparation stage, people intend to make change in the immediate future and
have a plan of action for their change, this stage is susceptible to action-oriented programs. In
the action stage, people have made specific and overt modifications in their lifestyles which are
significant and sufficient to reduce risks for disease. In the maintenance stage, people are
working to prevent relapse while employing fewer change processes than in the action stage.
Individuals stay in the maintenance stage from 6 months to 5 years before entering the final
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stage, termination. In the termination stage, individuals have zero temptation and reach 100%
self-efficacy. Regardless of circumstances, these people have no desire to return to their
unhealthy behavior, as if they never acquired the habit in the first place. Less than one in five
people reach this stage of change. Relapse is an additional construct related to the stages of
change and refers to the regression from a higher stage of change to an earlier stage of change.
People often cycle through the stages of change multiple times prior to successfully achieving
permanent change (Prochaska & Velicer, 1997, p 39). See Figure 1.

Figure 1. Transtheoretical Model of Health Behavior Change

Enter

Precontemplation

Termination

Contemplation

Maintenance

Preparation

Action
There are ten processes of change which have been identified for producing progress
through change, including consciousness raising, dramatic relief, self-reevaluation,
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environmental reevaluation, self-liberation, social liberation, counterconditioning, stimulus
control, contingency management, and helping relationships (Prochaska & Velicer, 1997, p 3940).
The final concepts of the theory are the concepts of decisional balance, self-efficacy, and
temptations (Prochaska & Velicer, 1997). Decisional balance relates to an individual’s relative
weighing of the pros and cons of change. Self-efficacy is the individual’s self-confidence or
belief that he or she can cope with specific high-risk situations without relapsing to the known
unhealthy behavior. Lastly, temptation refers to the urges to engage in a known unhealthy
behavior amid challenging situations (Prochaska & Velicer, 1997, p 40).
Project
Institutional Review Board
The project was reviewed and approved as an expedited study by the West Virginia
University Institutional Review Board (IRB) on December 14, 2017. There was limited risk to
the participants. Informed consent was obtained from those who agreed to participate in the
evaluative portion of the project. There was no deception used as part of the project
implementation.
Inclusion criteria. All adults (ages 18 and older) who were (a) active smokers, (b) had
lower extremity peripheral arterial disease (PAD), (c) were newly diagnosed with PAD, (d) were
cognitively intact, and (e) spoke English were eligible to participate. New patients were targeted
for this project because they had multiple encounters within a short period of time to be exposed
to the intervention and track behavior change. The Institutional Review Board (IRB) protocol
was amended during the enrollment period to include patients with PAD who had developed new
problems or symptoms related to the disease. The amendment was approved by the IRB on
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February 8, 2018. Patients with new problems or symptoms were added during the enrollment to
increase sample size and were believed to be very similar to newly diagnosed patients. The
inclusion criteria were in line with the theoretical framework of the project, specifically the
process of consciousness raising, which involves increased awareness about the causes,
consequences, and cures for a problem behavior. The hypothesis was that a new diagnosis or
new problems with the disease would cause these patients to be more receptive to education, and
more likely to be struck with a call to action, providing a teachable moment.
Recruitment and enrollment. The investigator and the medical assistants were
responsible for identifying individuals who were new patients who were active smokers with
PAD as recipients of disease-oriented smoking cessation education. The investigator determined
which patients met remaining inclusion criteria and asked them of their willingness to participate
in the evaluative portion of the intervention. In addition to receiving the smoking cessation
education, participants who met inclusion criteria were asked to provide additional feedback
after the intervention and have additional information recorded as part of the evaluation of the
project. They were also given an information sheet about the project and informed consent was
obtained prior to proceeding with the intervention.
Intervention
Preparing for the intervention. Prior to IRB approval, the investigator obtained
training in motivational interviewing and became certified as a tobacco treatment specialist to
learn how to better help people successfully quit smoking utilizing evidence-based education and
therapeutic interventions. The motivational interviewing skills were used to coach people toward
behavior change and help move them through the stages of change. A smoking cessation
education curriculum was created to provide patients identified as smokers with peripheral
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arterial disease (PAD) with disease-oriented smoking cessation education tailored to the
individual’s readiness to change. Pre-and post-intervention interview questions were developed
for participants related to smoking and PAD which helped evaluate their understanding before
and after the intervention.
Brief intervention plan. After being screened for inclusion criteria, participants who
met inclusion criteria received the brief intervention based on the 5 A’s of smoking cessation:
Ask, advise, assess, assist, and arrange (MDQuit, 2012a). The investigator (a) asked the
participant if it was okay to talk about his or her smoking, (b) assessed the participant’s smoking
by performing a comprehensive smoking history using a standardized tobacco cessation
interview form, (c) used information from the assessment of the smoking history to advise each
participant to quit by providing disease-oriented education about smoking and its relationship to
peripheral arterial disease, (d) assisted participants through education on available cessation
methods and their proper use and efficacy, and (e) arranged follow up for all participants. After
implementation of the 5 A’s, participants were asked to participate in the evaluative portion of
the intervention.
Screen patients. First, patients were screened for inclusion criteria, then asked if it was
okay to talk about his or her smoking. Patients were then asked if they would be willing to
evaluate their experience after the intervention. The information sheet was reviewed with those
who agreed to participate, and informed consent obtained. Next, a brief interview was conducted
using semi-structured questions to capture the participant’s perspectives on smoking. The
interview began by thanking the individual for participating in the project and agreeing to let the
investigator help him or her stop smoking. The questions from the interview included: (a) What
are some of the reasons you smoke?, (b) what are the situations or places you find yourself
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smoking most often?, (c) what thoughts do you have about quitting smoking?, (d) what have you
done to try to quit in the past?, (e) what stopped you from quitting up to now?, (f) have you ever
tried to change a different behavior in the past?, (g) what helped you to be successful with
changing that behavior?, (h) what do you think the hardest barrier to quitting would be today?, (i)
how successful do you think you would be if you tried to quit now?, (j) what kind of assistance
do you think you would need?, (k) how do you think your family and friends would react?, (l)
what is your understanding of the impact of smoking and your health?
Smoking assessment. Participant’s smoking was assessed using a standardized tobacco
cessation interview form. The comprehensive smoking history included past medical history and
social history such as occupation, lifestyle habits such as exercise, caffeine consumption, alcohol
consumption and illicit drug use. Additional smoking history was gathered including number of
cigarettes smoked per day, number of years smoking, how much time before they have their first
cigarette upon waking, and information about cravings such as having trouble not smoking
where prohibited and if they smoke even if they are ill and in bed most of the day. The questions
from this section are from a well-known, validated smoking assessment instrument known as the
Fagerstrom test for nicotine dependence (NIDA). This instrument assesses the intensity of
physical dependence to nicotine based on consumption, compulsion to use, and dependence. The
scoring is based on scoring yes/no items with a zero or a one and multiple-choice items from
zero to three with a final score yield from zero to ten. Higher scores indicate a more intense
physical addiction to nicotine, which is an important assessment tool when considering readiness
and ability to quit (NIDA). The questions from the scoring instrument were also used to describe
the participants’ smoking behaviors and tobacco dependence.
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Readiness to quit was assessed quantitatively by using a self-rating scale and qualitatively
by asking if participants believed they could quit. These self-rating data were quantified and used
to describe the sample. A stage of change was assigned to each participant based on self-rating
data and qualitative information from the interview. Additional history gathered included
reasons for smoking, reasons for wanting to quit, if applicable, and what barriers they could
identify. Finally, quit attempt history including number of quit attempts, methods used, and
family or social support was assessed.
Advise participants to quit. Information from the assessment of the smoking history
was utilized to advise each participant to quit by providing disease-oriented education about
smoking and peripheral arterial disease (PAD). The 5 R’s helped guide smoking cessation
interventions; the 5 R’s include relevance, risk, rewards, roadblocks, and repetition (Fiore, et al.,
2008). The education points included (a) smoking is the leading modifiable risk factor associated
with PAD, and only the individual can change or modify this risk factor; (b) smoking cessation
can reduce the symptoms related to PAD without any other intervention, and this lifestyle change
could potentially eliminate the need for medication or surgery; (c) smoking increases the risk of
complications related to PAD, including complications during, after, or without surgical
intervention; (d) recurrent disease after complications can be more difficult to treat, and can lead
to worsening disease and morbidities such as chronic pain or even limb loss; and (e) people with
PAD are at an increased risk of having other atherosclerotic diseases such as coronary artery
disease, which can lead to heart attacks, or carotid or cerebral artery diseases which could lead to
strokes.
After presenting all the educational intervention related to smoking and peripheral arterial
disease and advising participants to quit smoking as part of their medical management plan, they
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had the opportunity to decide if they were prepared to commit to quitting at the time of the
encounter. None of the participants committed to quitting during this study. Participants were
encouraged to keep the education they received in mind, and the investigator summarized the
information collected and the education given during the encounter.
Assisting the quit attempt. Participants were educated using evidence-based tobacco
cessation methods. All smoking cessation methods were explained, including “cold turkey”,
nicotine replacement therapy, and pharmacotherapy. Relevant data related to efficacy and correct
utilization of each method was discussed. After educating on all available options, the
investigator, together with the individual, made a recommendation for their best option(s).
Importantly, although none of the participants committed to quitting, the “STAR”
acronym was discussed. Participants were educated that once a decision was made to quit
smoking, they should: 1) set a quit date; 2) tell family, friends, and coworkers about their
decision; 3) anticipate challenges; and 4) remove tobacco products from the environment
(Cornuz, 2007).
Arranging follow up. Follow up was arranged for all participants based on their next
clinic appointment. During this encounter, the smoking history was updated, they received
additional brief education on the importance of quitting as it related to their disease process, and
they again were advised to quit using study protocol. Participants who did not have a follow up
scheduled or missed their follow up were contacted by telephone.
Participant evaluation of the intervention. At the three-month encounter, after the 5
A’s were implemented, the participants who agreed to participate in the evaluative portion of the
intervention were given a brief interview using semi-structured questions to evaluate their
thoughts and feelings about the intervention. Participants were encouraged to provide honest
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feedback and constructive criticism. They were informed that there were no right or wrong
answers to the questions, but that the questions will simply help the investigator better
understand how to help people manage their smoking and peripheral arterial disease, so they
have better outcomes. The questions started with asking how they have done with their smoking
since the first visit. Then they were asked how the smoking cessation intervention that was
provided impacted their smoking and if they made a quit attempt. Then they were asked what
about the intervention they found helpful, and what made those aspects of the intervention
helpful for them. They were also asked if there were any aspects of the intervention that weren’t
as helpful, and what made them less helpful in their experience. They were asked how the
intervention differed from other smoking cessation interventions they had experienced in the
past, and if the differences were helpful or not helpful. Finally, they were asked what they would
change about the intervention that could make it more beneficial to future patients. The
information gathered from the interview was recorded in an electronic log and saved for
qualitative review during post intervention analysis.
The Transtheoretical Model and Smoking Cessation
The theoretical model used for the development and implementation of the intervention
supported this project because of its historical origin to smoking cessation. Smoking cessation is
associated with the Transtheoretical Model, and much of the initial research was related to
smoking cessation. Since that time, the model has been developed and tailored to many other
health behaviors. Utilizing the model to help match the intervention to the stage of change a
person presented in was important to the project. Research related to the Transtheoretical Model
finds that 40% of at risk persons reside in the precontemplation stage of change, while 40% lie in
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contemplation, and 20% in preparation (Prochaska & Velicer, 1997, p. 41). Understanding this
distribution helped tailor the intervention to meet the needs of the patients.
Of the ten processes of change which help make up the theory, four closely relate to the
project and are defined further in relation to the project. Consciousness raising involves
increased awareness about the causes, consequences, and cures for a problem behavior. A goal
of the project was to improve awareness of the disease to patients through disease-oriented
smoking cessation education. Interventions that can increase awareness include feedback,
education, and confrontation. Self-liberation is both the belief that one can change and the
commitment to act on that belief (Prochaska & Velicer, 1997, p 40). Motivation research
indicates that people with more choices have greater commitment. For example, patients can be
provided a choice on how to attempt smoking cessation; action choices for patients are cold
turkey, nicotine fading, and nicotine replacement. Counterconditioning requires the learning of
healthier behaviors that can substitute for problem behaviors, such as nicotine replacement,
relaxation to counter stress, and assertion to counter peer pressure. Helping relationships
combine caring, trust, openness and acceptance as well as support for the healthy behavior
change. Rapport building, a therapeutic alliance, follow up calls, and buddy systems were
sources of social support experienced during the intervention (Prochaska & Velicer, 1997, p 40).
Feasibility
A major consideration for the practice change was whether it was feasible. Feasibility for
the practice change included being cost-effective, having the support of management, and being
compatible with clinic processes.
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Budget. The budget for the project included all the costs and the revenue incurred as part
of implementing the change project in the clinic. First, the cost of the nurse practitioner
providing education. This extra time was calculated using five-minute units calculated at $4.16
per unit. The smoking cessation education was conducted after the problem-focused encounter
and was billed as an “in addition to” service, meaning it was a separately billable service in
addition to the problem focused visit. The revenue generated from this additional coding varied
by payor and length of education provided. Patients received between three and ten minutes of
education were billed using the Current Procedural Terminology (CPT) code 99406, while those
receiving more than ten minutes of education were billed using the CPT code 99407. Most
patients were billed using the 99406 CPT code for education between three and ten minutes in
length, with the average revenue generated among payors being $13.53. Patients who received
more than ten minutes of education generated an average of $26.00. See table 1.
The cost of the tobacco treatment specialist training was also considered, a one-time cost
for a course any healthcare professional can take to become qualified to provide and bill for
tobacco cessation education. The investigator’s course was obtained for $445.00. Printed
materials to implement the project included 5 pages of information per participant which
summarized information about the intervention for consent purposes. The printing costs were
calculated at a rate of $0.10 per page, or $0.50 per participant. The staff involved in
implementation also had to be educated and trained on how to screen patients eligible for the
education. For this project, about ten minutes was spent educating the medical assistants on the
developed process and was incorporated into a monthly staff meeting. The time spent to screen
each patient was less than one minute and thought to be negligible to the project budget.
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Cost-benefit. One of the top factors in feasibility is whether the benefits of the
intervention outweigh the costs of implementation. During the study, twenty patients received
smoking cessation education which was documented as an “in addition to” service in the medical
record. Among these patients, sixteen received three to ten minutes of education while four
received greater than ten minutes of education. The formula to calculate the revenue is X1
(number of 3-10 minute interventions) x $13.53 + X2 (number of 10 or more minute
interventions) x $26.00 = Y (total revenue). The extra revenue generated was estimated at
$320.48. The time the nurse practitioner spent performing the education was calculated based on
units. For the analysis, five minutes of time was calculated for patients billed for three to ten
minutes of education with ten minutes of time calculated for those who received ten or more
minutes. The formula for the implementation cost is X1 (number of 3-10 minute interventions) x
$4.16 + X2 (number of 10 or more minute interventions) x $8.32 = Y (NP implementation cost).
Using this formula, the nurse practitioner’s time was calculated at a cost of $99.84. Printed
materials for the education was calculated at $0.50 per person, for a total of $10. The formula
for net revenue is Y1 (total revenue) – Y2 (implementation cost) – printed material cost = net
revenue. Therefore, the total additional revenue generated by the intervention exceeded the cost
by $210.64.
Table 1. Project Budget
Expense
Nurse Practitioner
Printing
Billable Services

Per diem
$4.16 per unit (5
minutes)
$0.10/sheet, 5 sheets
per participant
$13.53 CPT 99406
$26.00 CPT 99407

Total

N
16 @ 5 minutes
4 @ 10 minutes
20

Cost
$99.84

16 @ 99406
4 @ 99407

($320.48)

$10.00

($210.64)

CPT= Current Procedural Terminology, 99406 = CPT code for three to ten minutes education, 99407 = CPT code
for greater than ten minutes of education
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Projected costs and benefits. The pilot project was implemented to a small subpopulation within the clinic. In one year, there are over 2,800 patient encounters within the
clinic. Analysis revealed that 24% or approximately 672 of those patients are active smokers.
Nearly all these patients would benefit from smoking cessation to improve their vascular and
overall health and would be potential candidates for smoking cessation education if the project
was expanded in the clinic. If each active smoker received smoking cessation education for five
minutes, it would cost $4.66 per patient while bringing in average revenue of $13.53. Therefore,
adding this service as part of standard care for all smokers could generate as much as $5,960
annually.
Resources. The resources required for this intervention included a dedicated staff that
bought into the project, the electronic medical record, and financial resources including the time
required of the investigator to implement the intervention and the costs of printed materials.
Staff. Staff were trained in identifying persons who smoked and had a diagnosis of
peripheral arterial disease (PAD) so they could be properly identified as appropriate recipients of
the intervention. Staff also documented an up-to-date smoking history for each participant in the
medical record to help the investigator with data collection and identifying individuals who met
inclusion criteria. Finally, the staff scanned relevant data into the electronic medical record.
The clinic has two to three medical assistants responsible for patient care during each
clinic day. During Monday, Wednesday, and Friday clinic times, only the nurse practitioner was
in clinic, and was easily able to identify patients with PAD and provide the intervention as it was
designed. On Tuesdays and Thursdays there were at least two providers in clinic, which is when
the medical assistants were utilized to help flag patients who met the inclusion criteria to receive
the intervention, regardless of which provider was seen.
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Organizational factors. The mission of the practice is to provide excellent care for
patients with vascular disease and to limit disability associated with their disease. This aligned
well with the goals of the project as smoking is a major contributor to the development of
vascular disease, and to morbidity and mortality after diagnosis. The practice is an independent
vascular surgery specialty clinic which is owned and operated autonomously from the hospital;
this makes cost-effectiveness a priority. The clinic has a high patient volume with over 100
patient encounters a week and has three providers, a physician and two nurse practitioners. The
number and workload of providers had to be considered when implementing a project that
required more time for select patient encounters. Patient volume, proper documentation and
coding, and efficient utilization of resources are all important to an independent practice which
requires a positive cash flow. The project helped increase revenue by providing additional
services to some patients, which, with proper documentation and coding, provided additional
reimbursement for the services provided.
Key site support. The medical director is a vascular surgeon and has shown interest in the
goals and outcomes of the project throughout the process. He has offered input and support for
the project. He has stated that he would like there to be a publication involved with the project,
which will be good for dissemination of the outcomes to the medical community. Other staff
members, too, bought-in to the project and were instrumental in its success.
Project Objectives
There were five objectives identified for this project. Two process or formative
objectives and three outcome or summative objectives. The two process objectives were: 1) By
the conclusion of the intervention, 75% of newly diagnosed patients with peripheral arterial
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disease will have received the defined intervention, and 2) after the study, the participants would
believe that the intervention was helpful and disease-oriented.
The three outcome objectives included: 1) After the intervention, smokers who received
disease-oriented smoking cessation education would have reduced the number of cigarettes they
smoked daily by at least 50%; 2) after the intervention, smokers receiving the intervention would
have moved at least one stage forward in their readiness to change, and 3) after the project, a
cost/benefit analysis would show that the intervention was at least cost neutral.
Evaluation of Data
The project was evaluated using both quantitative and qualitative data to evaluate
acceptability to participants, effectiveness of the intervention to support smoking cessation, and
the cost-effectiveness of the intervention within a specialty practice.
Process evaluation plan. The first objective for process evaluation was the qualitative
evaluation of whether participants found the intervention to be helpful. This objective was
evaluated using narrative data gathered from patient interviews pre-and post-intervention.
Participant’s evaluation of the helpfulness of the intervention was captured through narrative
responses to the post-intervention interview. Pre and post-intervention stage of change were also
evaluated using narrative responses. Responses to the questions from the interview were
documented in the investigator’s log book. Data from the investigator’s log book were evaluated
using thematic analysis.
The second process objective was that 75% of smokers with a new diagnosis of or
problem related to peripheral arterial disease (PAD) would receive smoking cessation education.
This was evaluated utilizing chart review to determine how many people who had both a
documented smoking history and diagnosis of PAD received smoking cessation education.

INCORPORATING SMOKING CESSATION EDUCATION

28

Outcome evaluation plan. There were three outcome objectives evaluated for the
project. Outcome one was evaluated by comparing the number of cigarettes smoked preintervention to number of cigarettes smoked three months after the intervention. Outcome two
compared differences in readiness to change prior to the intervention and again three-months
after the intervention based on the Transtheoretical Model. Outcome three was evaluated using a
brief cost-benefit analysis which was performed using data related to the costs of implementing
the project versus revenue generated from the education as evidenced by a comparison of
revenues generated by successful documentation, coding, and reimbursement for tobacco
cessation intervention with the expenditures dedicated to the project.
Results
The analysis of the qualitative and quantitative data revealed interesting information
about the intervention and its impact on the participants. The sample is described, followed by
pre-intervention data, post-intervention data, and finally final outcomes reported by objectives.
Sample. During the implementation of the project, there were 394 patients who had a
diagnosis of peripheral arterial disease (PAD). Among this group, 102 were active smokers, 101
were non-smokers, and 191 were former smokers. Ninety-one patients who had a chief
complaint of PAD were screened for inclusion in the project. Twenty-nine active smokers had a
new diagnosis or problem related to PAD. Among these, 20 had documented education related to
smoking and PAD. The final sample included 9 participants who were willing to talk about their
smoking and evaluate the intervention.
Nine participants, 5 males and 4 females, agreed to evaluate the evaluation component of
this project. All participants were white, with an average of 59.1 years of age (range 52-67 years
of age). Participants smoked an average of 40 years (range 25-50 years) at about one pack (19.77
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cigarettes) a day (range 8-35 cigarettes). There were four participants with Medicare and three
with Medicaid, the other two had private insurance.
Pre-intervention assessment. As a group, the sample was in the contemplation stage at
their first visit, with participants ranging from pre-contemplation to action stage. Their
Fagerstrom score averaged 5.3 (range 2-8), which represents moderate dependence to nicotine
(NIDA). The group response to the question whether they were ready to quit had average 6.8
(range 1-10).
Pre-intervention interview analysis. Descriptive data from the pre-intervention interview
revealed information about why participants smoked and other information about their smoking
history.
Smoking behaviors and quit attempts. There were some common themes among
participants for reasons they smoked, such as stress (7), habit (4), and inability to quit (5).
Participants reported smoking the most in their car (4), after meals (4), and in social settings (3).
Many believed they needed to quit (8), either for their health (5), because their family wants
them to (3), or because it is expensive (4). Most of the participants had attempted to quit in the
past (8), with everyone having attempted to quit cold turkey in the past, and many others having
tried some form of nicotine replacement (6). Three participants had tried a pharmacologic
cessation aid, and two others stated they had thought about it but were afraid of side effects.
Motivators and barriers. More than half of the patients had successfully changed a
different behavior (5), most of those having quit alcohol (3), with one having been previously
dependent on pain medication. Health (3) and necessity (2) were the most commonly cited
reasons these participants gave for being successful. Stress (6), previous failures (3), and
withdrawal symptoms (4) were the main reasons participants gave for not quitting smoking to
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date. The participants’ most difficult barriers to quitting were similar to reasons they smoke and
what has stopped them up to now; they cited stress (6), habits (4), and years smoking (3) as
biggest barriers.
Smoking cessation self-efficacy. The participants were not optimistic about their ability to
quit, with only a few believing they could successfully quit with help (3).
Smoking cessation facilitators. Mentorship from former smokers (2), willpower (3), and
environmental changes such as friends and family quitting (3) were all common answers to what
assistance would be needed to successfully quit. All but two participants stated that friends and
families would be supportive of quitting smoking, with the other participants being unsure if they
could get their spouse or significant other to quit with them or “buy in” to their quit attempt (2).
Impact of smoking and health. The participants had difficulty answering the question of
what their understanding was about the impact of smoking and their health. Prompting was
required for many to provide a response to the open-ended question. Participants believed that
smoking was not good for their health. Most stated that it affected their breathing (5), and a few
stated they were worried about the risk of a heart attack (4). None responded that their current
issues with peripheral arterial disease may be related to smoking. Interestingly, several (3)
participants stated that they believed it was too late to change their health by quitting smoking,
with one stating that “something had to kill him”, and it wasn’t worth quitting at his age.
Post-intervention. After the intervention, the group moved forward in their readiness to
change, from the contemplation stage to the preparation stage. They ranged from the precontemplation stage to the action stage. One patient quit smoking during the study for about
one-month but returned to smoking three cigarettes daily by the three-month follow up. Another
patient reported as quit at the three-month follow up encounter, however she had just been
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discharged from the rehab facility where she was unable to smoke. The group averaged about
19.8 cigarettes a day at the first visit, which decreased to about 7.75 cigarettes (range 0-10
cigarettes) by their three-month follow-up.
Post-intervention interview analysis. A thematic analysis was performed on interview
data collected during the three-month follow-up interview. Information from the interviews was
used to identify themes related to participants’ thoughts on whether the intervention was helpful.
As a group, the majority answered that the intervention was helpful (5), while two participants
stated they could not recall the education to make a judgement. There were three recurring
themes from the question about what was helpful: 1) Conversation (3), 2) fear or stress (3), and
3) thinking (3). The fear could be a positive response, as one patient said the intervention was
eye-opening and put the “fear of God” in him to make a change for his health. The following
themes reflected what the group did not find helpful: 1) Length of talking (3), 2) too much
information (2), and 3) stress (5). One participant stated no provider had spent “that much time
talking” to her about smoking, and that our conversation was the first time she became mad at a
provider over the conversation about smoking. Their thoughts on the difference in this
intervention from others included: 1) Longer conversation (4), 2) not forceful (3), and 3)
thought-provoking (3). For those who offered feedback on what could be changed about the
intervention, the recommendations to stay brief (2), provide more written information (2), and
creating a “cigarette 12 steps program” (1) were the most enlightening.
The interviews also revealed other information that was meaningful qualitative data for
this study. The conversations with participants revealed actions they had taken related to
smoking over the three-month period, barriers they faced, and successes they had. Many patients
admitted to thinking more about their smoking and had made some attempts to cut back (4).
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Two patients had called the quitline and obtained nicotine replacement products to try to help
them reduce their smoking. Participants identified stress as a big barrier to quitting. Most
participants identified the first cigarette of the day as the most difficult to eliminate and were
unsure of what they could do to change habits to eliminate all cigarettes smoked throughout the
day (4). Several participants pointed out that other conditions such as chronic obstructive
pulmonary disease (COPD) made them more fearful and motivated them to attempt to quit (3).
One participant specifically states that her lung doctor got her to commit to quitting after a
hospitalization from COPD. She admitted that this intervention likely opened the door to
thinking more about her smoking, but that the COPD scare really pushed her through.
Process and outcome evaluation. The final evaluation of the outcomes revealed
whether the objectives of the project were met.
Process evaluation. There were two process objectives which were evaluated.
Objective 1. Twenty-nine patients presented with a new or newly complicated diagnosis
of peripheral arterial disease. Among those, 20 had documentation of smoking cessation
education during their visit. Therefore, about 69% of patients who met inclusion criteria
received the intervention, short of the goal of 75%.
Objective 2. After the study, most of the participants (6) believed that the intervention
was helpful and several stated that the content about their disease was thought provoking and
made them more concerned about their smoking (3).
Outcome evaluation. There were three outcome objectives which were evaluated.
Objective 1. After the intervention, participants who received disease-oriented smoking
cessation education reduced the number of cigarettes they smoked daily from an average of
19.77 to 7.75, a difference of 60.8%, greater than the goal of 50%.
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Objective 2. Participants who received the intervention moved forward 1.0 stages, which
met the goal of moving at least one stage forward in their readiness to change.
Objective 3. After the project, a cost/benefit analysis revealed that the intervention was
cost-effective; the total additional revenue generated by the intervention outweighed the cost by
$210.64.
Discussion and Recommendations
Challenges
Many of the goals of the intervention were met and positive quantitative and qualitative
data were revealed during the study. However, there were several challenges met during
implementation that limited the study and are addressed in this section.
Sample size. During project implementation, the educational intervention was provided
to twenty patients in the clinic. Nine patients agreed to participate in the project evaluation.
Notably, the small sample size limited both quantitative and qualitative evaluation. Additionally,
one patient could not be reached for telephone follow up and did not attend their follow up
appointment, leaving only eight patients for final evaluation. Despite the small sample size, this
pilot study provided useful information about the feasibility and potential effectiveness of
implementing a smoking cessation education program into a specialty clinic setting.
Barriers to recruitment. There were unforeseen circumstances which led to a smaller
than expected sample size for this project. First, during implementation it was discovered that
fewer patients than anticipated were active smokers. Many patients had quit smoking, but it was
not reflected in their medical records. Additionally, there are many patients, especially older
patients, who deny any history of smoking. To counter this barrier, Institutional Review Board
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approval was obtained to modify the inclusion criteria to include patients with new problems
related to peripheral arterial disease to increase the number of individuals eligible to participate.
Importance of proper documentation. Clinicians in all practice settings should take
extra care to ensure that proper documentation of patient history occurs at every encounter. The
implementation of this change project revealed that many patients had outdated information in
the social history related to smoking, such as being documented as a current smoker although
they had quit. This information should be considered when deciding whether an intervention
could be cost-effective in a clinical setting, as having fewer smokers than anticipated will
decrease the available population to deliver an intervention.
Results and Implications
The analysis of the qualitative and quantitative data revealed interesting information
about the intervention and its impact on the participants. Further discussion regarding the preand -post-intervention data is discussed in this section.
Analysis of pre-intervention qualitative data. The pre-intervention interview and other

intake information provided useful narrative data regarding where patients were prior to the
intervention. The interview provided insights into their smoking behaviors and previous quit
attempts, motivators and barriers to quitting, their self-efficacy regarding smoking cessation, and
smoking cessation facilitators.
Smoking behaviors and quit attempts. There were some common themes among
participants for reasons they smoked, their behavior patterns with smoking, and their previous
attempts to quit. The data suggests that smoking affects many people in similar ways, but it does
not make it easier to quit. An important consideration from the data is that many smokers want
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to quit, and most have tried in the past. When implementing an intervention, gaining an
understanding of your sample will help better tailor the intervention to their needs.
Motivators and barriers. Stress, previous failures, and environmental barriers are all
common reasons that people fail to quit. Stress is present in everyone’s lives, although it varies
widely in types and amounts. Addressing reasons for stress and teaching alternative coping
mechanisms can help break down this common barrier. Common environmental factors include
smoking in the car, after meals, or in social settings. These common smoking triggers can be
individually explored with follow-up questions to gather more about the underlying reasons that
may be leading to recurrent failures to quit. Expanding on the interview can open more
opportunities to implement the 5 R’s, which incorporate the concepts of relevance, risk, rewards,
roadblocks, and repetition.
Smoking cessation self-efficacy. Smokers and providers not understanding the
underlying reasons patients smoke and why previous quit attempts have failed can lead to the
issue of poor self-efficacy, or individuals not believing they can successfully quit, which was
reflected in the data.
Smoking cessation facilitators. The participants offered some insight into poor selfefficacy could be encountered, such as utilizing former smokers to mentor current smokers
toward a successful quit. Otherwise, serious health issues or “necessity” may be the only strong
motivating factors for patients to quit. The participants in this study attributed previous behavior
changes such as quitting alcohol or prescription drugs to these reasons. The challenge with
tobacco addiction, when compared to alcohol or opioid or drug abuse is that it doesn’t alter
people’s behavior or lead to legal problems, leaving only serious health issues as strong
motivators for people to quit, which are often later stages of disease.
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Exploring possible “calls to action” or reasons to quit is part of the 5 R’s and is a major
consideration for individuals developing a smoking cessation intervention. The participants in
this study had low self-efficacy from previous failures and were not strongly motivated to quit
for their peripheral arterial disease, but they did reduce their smoking over the course of the
study. The literature discusses the dose-dependent relationship between smoking and peripheral
arterial disease, and although complete cessation is ideal, significant reductions should be
valued.
Health priorities. Health, wellness, and quality of life are all important aspects to
consider when developing and implementing health promotion or disease prevention
interventions. It is important, however, to consider that individuals have different priorities
regarding their health and lifestyle choices. Educating individuals about their behavior and why
it is unhealthy may be ineffective if they are already aware of the information but do no not care
to change. This was demonstrated during this intervention, as one participant explained that he
thought it was too late to quit and he didn’t have the desire to. His belief was that something had
to kill him, and it wasn’t worth quitting at his age. Alternatively, there were participants who
found the disease-oriented smoking cessation education to be thought-provoking, with some
having a fearful response to how continued smoking may impact their disease in the future. For
these individuals, education may lead to a call to action to change their behavior.
Analysis of post-intervention qualitative data. The sample for the study found the
intervention helpful, but notably, many found it hard to recall the intervention in detail. A larger
group may reveal more insights into what was helpful and why. There were many important
ideas that emerged from the narrative data gathered from participants about the intervention,
such as opinions on the length of the conversation, the amount of written information desired, the

INCORPORATING SMOKING CESSATION EDUCATION

37

willingness of people to try pharmacological options for smoking cessation, and individual’s
priories regarding health.
Length of conversation. Participants in the study expressed different opinions on the
length of the conversation during the smoking cessation education. The recurring theme was that
in investigator spent more time discussing smoking cessation than they were accustomed to.
What differed was participants opinions and preferences on whether the conversation was too
long. When developing or implementing an intervention related to uncomfortable topics, one
must consider participants’ preferences on length of conversation and be able to tailor the
intervention based on how long an individual is willing to spend on the topic. Being able to read
cues that you are losing an individual’s attention should bring you to a stopping point where you
can summarize information, then potentially provide a written summary of the education.
Written information. The amount and type of written information provided during an
intervention is another important consideration. Written information can be a good tool to
reinforce, summarize, or supplement verbal education provided to patients. Participants in the
study offered recommendations for the amount and type written information for the study. Some
recommended more than the summary the was provided to be included. Other options could
include activities for participants to complete at home between encounters or “fact sheets” about
smoking in general. These are often included in community smoking cessation classes and could
be useful in the clinic setting as well. Additionally, one participant recommended a “12 step for
cigarettes”. This could be developed and put into written for and provided to patients as part of
supplemental information and/or incorporated into the verbal education.
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Cessation aides. There are multiple options for approaches smokers can utilize for
smoking cessation. For this intervention, all options were discussed as available options,
including “cold turkey”, nicotine replacement, or pharmacological aides. Most participants had
tried both quitting cold turkey or nicotine replacement in the past. As a group they seemed
comfortable with these methods, although they were not confident in their efficacy given
previous experiences. Alternatively, pharmacological aides had only been utilized by three of the
participants. Among them, two had some success, but one stopped the medication because of
side effects. Two other participants expressed concern with the potential side effects of the
pharmacological agents and were against their use. When implementing an intervention, it is
important to consider all the alternatives available for intervention.
Continuation of the Project
This pilot project provided insights into the feasibility of implementing a brief but
intensive intervention into a specialty clinic setting. At a vascular surgery practice, virtually all
conditions treated are impacted by smoking, and anyone who smokes can be educated on the
impacts of smoking and their disease process with only small modifications in delivery based on
the condition. Implementing this education as the standard of care for all active smokers within
the practice will help improve the quality of care, follow evidence-based guidelines, and increase
practice revenue.
The project also provided a better understanding of the barriers to incorporating more
tobacco cessation education into the practice and what changes would improve care delivery.
First, more than one provider within the clinic should be trained in tobacco cessation to be able
to reach more patients during high volume clinic days. Alternatively, a non-provider could be
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trained as a tobacco treatment specialist and be designated to follow the treatment protocol and
educate patients identified as appropriate recipients of tobacco cessation education.
Implementation in other settings. Education on smoking cessation and assistance with
quitting are typical in the primary care setting, but research shows that it is lacking in specialty
clinic settings. This project showed that with proper education of staff and commitment to the
goal of improving patient care, effective smoking cessation education can be provided in the
specialty setting in a cost-effective way. Reimbursement is possible for tobacco cessation
education in specialty clinics with proper documentation and coding if performed by a trained or
licensed professional. A variety of medical professionals qualify to be tobacco treatment
specialists, from physicians to medical assistants, however formal training is not required for
reimbursement from licensed professionals.
Attainment of DNP Essentials
Scientific Underpinnings for Practice
The development and implementation of this change project required research of the
pathophysiology of peripheral arterial disease and smoking along with evidenced-based
guidelines for implementing smoking cessation interventions across a variety of settings.
Secondly, a new practice approach for smoking cessation intervention in a specialty clinic setting
was developed, implemented, and evaluated.
Organizational and Systems Leadership for Quality Improvement and Systems Thinking
The developed intervention was a problem-focused clinical practice initiative intended to
improve the quality of care delivered within the organization. The cost-effectiveness of the
practice change initiative was analyzed to ensure long-term feasibility.
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Clinical Scholarship and Analytical Methods for Evidence-based Practice
Clinical scholarship was demonstrated through the design and implementation of
processes to evaluate the outcomes of the practice change initiative against standard care.
Analytical methods were used to appraise existing literature to determine the best methods and to
implement and evidence-based intervention.
Information Systems/Technology and Patient Care Technology for the Improvement and
Transformation of Health Care
An important piece of the development and implementation of the project was evaluation
of how healthcare technology and the electronic medical record could be utilized to facilitate
efficient implementation of the change project.
Health Care Policy for Advocacy in Health Care
As part of the efforts to fully understand health care policy for advocacy in health care,
the centers for Medicaid and Medicare Services and other health insurance policy information
regarding coverages and billing for smoking cessation were researched. Information from the
project and education provided was documented in the medical record based on available
guidelines for billing and coding. This information is useful to other providers in the
participants’ care team and to demonstrate to insurances that smoking cessation is being
discussed or attempted.
Interprofessional Collaboration for Improving Patient and Population Health Outcomes
An interprofessional team was led by the student to analyze existing practices and
develop a new standard of care for implementation in the practice setting. Effective
communication and collaboration skills were utilized in implementing best practice using the
chosen transtheoretical model.
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Clinical Prevention and Population Health for Improving the Nation’s Health
The student synthesized concepts, including psychosocial dimensions and cultural
diversity, related to clinical prevention and population health in developing, implementing, and
evaluation interventions to address health promotion and disease prevention efforts in smoking
cessation. Additionally, the care delivery model in the project from perspective of community
health and the cultural and socioeconomic dimensions of health was evaluated.
Advanced Nursing Practice
The student developed and implemented an intervention and evaluated it for links among
practice, organizational, population, fiscal, and policy issues with a focus on nursing science and
other sciences. The intervention involved developing and sustaining therapeutic relationships
with patients and health professionals to facilitate optimal care and patient outcomes.
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Appendix I. Tobacco Cessation Interview Form
Tobacco Cessation Interview Form
TOBACCO USE

1.

How soon after you awaken do you smoke your first cigarette?

2.

Do you find it difficult to refrain from smoking in places where it is
forbidden?

3.

Which cigarette would you hate the most to give up?

4.

How many cigarettes per day do you smoke?

5.
6.

Do you smoke more frequently during the first hours after
awakening than during the rest of the day?
Do you smoke even if you are so ill that you are in bed
most of the day?

READINESS TO CHANGE

How badly do you want to quit now (scale 1-10)

Do you think you can successfully quit with help?
STAGE OF CHANGE
c Precontemplative
c Contemplative
c Planning
c Active
c Maintenance
c Relapse
c Recycle
TOBACCO USE QUESTIONNAIRE
Why do you smoke?

Why do you want to quit?

What are some barriers to quitting?

After 60 minutes (0)
31-60 minutes (1)
6-30 minutes (2)
Within 5 minutes (3)
No (0)
Yes (1)
The first in the
morning (1)
Any other (0)
10 or less (0)
11-20 (1)
21-30 (2)
31 or more (3)
No (0)
Yes (1)
No (0)
Yes (1)
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QUIT ATTEMPT HISTORY

Have you ever tried to quit prior to today?

What methods did you use?

Did you have family/friend support?
TRIGGERS

ADDITIONAL HISTORY DISCUSSED
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Appendix II. Descriptive Questions
1. How many patients in sample smoke their first cigarette…
a. Within 5 minutes of waking up?
b. 6-30 minutes within waking up?
c. 31-60 minutes within waking up?
d. After 60 minutes of waking?
2. How many patients find it difficult to refrain from smoking in places where it is
forbidden?
a. How many do not find it difficult to refrain?
3. How many patients find the first cigarette in the morning the hardest to give up?
a. How many find a different cigarette the most difficult?
4. How many cigarettes a day does patient smoke?
a. 10 or less
b. 11-20
c. 21-30
d. 31 or more
5. How many patients fine that they smoke more frequently in the first hours after
awakening than during the rest of the day?
6. How many patients said they would smoke even if they were ill and in bed most of the
day?
a. How many said they wouldn’t?
7. How many patients did not want to quit smoking at all? (1-2/10)
a. How many would consider quitting? (3-6/10)
b. How many are considering quitting? (7-8/10)
c. How many want to or are trying to quit? (9-10/10)
8. How many patients believe they can successfully quit smoking with help?
a. How many do not believe they can quit?
9. How many patients have tried quitting in the past?
a. How many have never tried?
10. How many patients have tried quitting cold turkey?
a. With nicotine replacement therapy?
b. With prescription medication?
c. With cognitive behavioral therapy?
d. With combination therapy?
11. Average years smoking
a. Range
12. Number of cigarettes smoked per day
a. Range
b. average
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Appendix III. Qualitative Interview Questions

Pre-Intervention
1. What is your understanding of the impact of smoking and your health?
a. Perception of risk
2. What are your reasons for smoking?
3. What are your thoughts about quitting smoking?
a. Do you want to quit?
b. Have you tried?
4. What have you tried to quit smoking in the past?
5. What do you see as barriers to quitting smoking?
6. Do you think that you can quit smoking?
7. How do you think your family and friends will react to your commitment to quit
smoking?

Post-Intervention
1. Do you think that the smoking cessation intervention we provided was helpful to your
quit attempt?
2. What about the intervention did you find helpful?
3. What about the intervention did you find as not helpful?
4. How was this intervention different from other tobacco cessation interventions you have
experienced in the past?
5. What would you change about the intervention to improve it for future patients?
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